Back View Full Paper ↗

EyeNova

Development of a Novel Slit-Lamp Replication and ResNet Platform for Early Non-Invasive Detection of Glaucoma and Kayser-Fleischer Rings in Neurological Wilson’s Disease and Liver Failure.

The Challenge

Wilson’s disease is an autosomal recessive disorder causing toxic copper accumulation. A key diagnostic feature is Kayser-Fleischer (KF) rings, which are often missed in early stages, especially in darker irises. Traditional slit-lamp exams require expensive equipment ($5,000–$10,000) and specialists, limiting global access. EyeNova bridges this gap with an AI-driven, accessible diagnostic tool.

KF Ring Placeholder
(Insert your image here)
Kayser-Fleischer Ring Detection

Biomimetic Inspiration

Inspired by the mantis shrimp—which detects 16 distinct photoreceptor channels from UV to IR—EyeNova expands perception beyond human trichromatic vision. The pipeline applies intensity scaling, channel-wise transformations, and integrates infrared (IR) imaging to amplify subtle chromatic differences that are typically invisible.

Mantis Shrimp Placeholder
(Insert your image here)
Mantis Shrimp Visual System

Hardware Engineering

Modeled in Fusion 360 and 3D-printed for rapid prototyping, the system operates on a Raspberry Pi with an IR camera. Iteration V2 features an organic, eye-shaped eyecup for optimal focus, expanded housing for status LEDs, and improved airflow. Total hardware cost remains radically accessible at under $50.

Machine Learning Architecture

Two modified ResNet-50 Convolutional Neural Networks were trained using TensorFlow. By augmenting conventional RGB inputs with IR data and multispectral transformations, the deeper convolutional layers can extract high-dimensional features simulating true multispectral perception.

Streamlit UI / Glaucoma Placeholder
(Insert your UI screenshot here)
Real-Time Diagnostic Interface

Clinical Results & Impact

Rigorous testing proved the system's clinical viability. The Glaucoma model achieved 89.40% accuracy (92.6% sensitivity), while the KF Ring model reached an exceptional 93.43% accuracy, significantly outperforming average human diagnostic rates (60–70%). EyeNova offers a highly scalable, point-of-care solution that democratizes specialized ophthalmic screening.